Journal
CHEMSUSCHEM
Volume 7, Issue 12, Pages 3521-3533Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cssc.201402313
Keywords
active pharmaceutical ingredient; process design; green pharmacy; heterogeneous catalysis; life cycle assessment
Funding
- European Community [CP-IP 246095-2 POLYCAT]
Ask authors/readers for more resources
As the demand for new drugs is rising, the pharmaceutical industry faces the quest of shortening development time, and thus, reducing the time to market. Environmental aspects typically still play a minor role within the early phase of process development. Nevertheless, it is highly promising to rethink, redesign, and optimize process strategies as early as possible in active pharmaceutical ingredient (API) process development, rather than later at the stage of already established processes. The study presented herein deals with a holistic life-cycle-based process optimization and intensification of a pharmaceutical production process targeting a low-volume, high-value API. Striving for process intensification by transfer from batch to continuous processing, as well as an alternative catalytic system, different process options are evaluated with regard to their environmental impact to identify bottlenecks and improvement potentials for further process development activities.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available